Retention of Patient Records

Question 1

Source of final disposition of each unit of blood or component

Answer 1

10 years

Question 2

Therapeutic apheresis: physician request, patient ID, dx, type of procedure, method, vital signs, extracorporeal blood volume, nature and volume of component removed, nature and volume of replacement fluids, any adverse events, meds administered

Answer 2

5 years

Question 3

Therapeutic phlebotomy: physician request, patient ID, dx, vital signs, volume removed, any adverse events

Answer 3

5 years

Question 4

Requests for blood an blood components

Answer 4

5 years

Question 5

Order for blood, components, tests, and derivatives

Answer 5

5 years

Question 6

Test results and interpretation of patient’s ABO and Rh

Answer 6

10 years

Question 7

Additional testing for alloantibodies

Answer 7

10 years

Question 8

Control system results appropriate to the mehod

Answer 8

10 years

Question 9

Pretransfusion testing for autologous units

Answer 9

10 years

Question 10

Difficulty in blood typing, clinically significant antibodies, significant adverse events, and special transfusion requirements

Answer 10

Indefinite

Question 11

Test results for serologic CXM

Answer 11

10 years

Question 12

Detection of ABO incompatibility when no antibodies are detected

Answer 12

10 years

Question 13

2 determinations of the recipient’s ABO group

Answer 13

10 years

Question 14

Computer detection of ABO incompatibility

Answer 14

10 years

Question 15

ABO/Rh of neonatal recipients

Answer 15

10 years

Question 16

Selection of compatible units when initial screen for neonates antibodies

Answer 16

10 years

Question 17

Testing of neonate’s serum for isohemoagglutinins if a non-group-O neonate is to receive non-group-O RBCs

Answer 17

10 years

Question 18

IUT policy

Answer 18

10 years

Question 19

Irradiation of cellular components if applicable

Answer 19

10 years

Question 20

Final inspection of blood and components before issue

Answer 20

10 years

Question 21

Verification at issue of:

1. Intended recipient’s 2 independent identifiers, ABO group, Rh type
2. Donation ID #, donor ABO and Rh
3. Interpretation of CXM
4. Special requirements
5. Expiration date and time
6. Date and time of issue
7. Personnel issuing and accepting components

Answer 21

10 years

Question 22

Signed statement from requesting physician indicating that the clinical situation was urgent to require release of blood before completion of compatibility testing or ID testing

Answer 22

10 years

Question 23

Notification of abnormal test results

Answer 23

10 years

Question 24

Recipient consent

Answer 24

5 years

Question 25

Verification of the following information before transfusion:

1. Intended recipient’s 2 independent identifiers, ABO group and Rh type
2. Donation ID #, donor ABO and Rh
3. Interpretation of CXM
4. Special requirements
5. Expiration date or time

Answer 25

5 years

Question 26

Verification of patient identification before transfusion

Answer 26

5 years

Question 27

Patient’s medical record: transfusion order, documentation of patient consent, component name, donation ID #, date and time of transfusion, pre- and post-transfusion vital signs, amount transfused, transfusions and any adverse events

Answer 27

5 years

Question 28

Immediate evaluation of suspected transfusion reaction

Answer 28

10 years

Question 29

laboratory evaluation and review of clerical information related to suspected adverts events

Answer 29

10 years

Question 30

Interpretation of the evaluation of suspected transfusion reaction

Answer 30

10 years

Question 31

Evaluation and interpretation of delation transfusion reactions

Answer 31

10 years

Question 32

Look-back to identify recipients who may have been infected with HCV or HIV

Answer 32

10 years